Association of smoking and electronic cigarette use with wheezing and related respiratory symptoms in adults: cross-sectional results from the Population Assessment of Tobacco and Health (PATH) study, wave 2
Top Cited Papers
- 1 March 2020
- journal article
- research article
- Published by BMJ in Tobacco Control
- Vol. 29 (2), 140-147
- https://doi.org/10.1136/tobaccocontrol-2018-054694
Abstract
Background Wheezing is a symptom of potential respiratory disease and known to be associated with smoking. Electronic cigarette use ('vaping') has increased exponentially in recent years. This study examined the cross-sectional association of vaping with wheezing and related respiratory symptoms and compare this association with smokers and dual users. Methods The Population Assessment of Tobacco and Health study wave 2 data collected from October 2014 to October 2015 with 28 171 adults were used. The cross-sectional association of vaping with self-reported wheezing and related respiratory symptoms relative to smokers and dual users of tobacco and electronic cigarettes were studied using multivariable logistic and cumulative logistic regression models with consideration of complex sampling design. Results Among the 28 171 adult participants, 641 (1.2%) were current vapers who used e-cigarettes exclusively, 8525 (16.6%) were current exclusive smokers, 1106 (2.0%) were dual users and 17 899 (80.2%) were non-users. Compared with non-users, risks of wheezing and related respiratory symptoms were significantly increased in current vapers (adjusted OR (aOR)=1.67, 95% CI: 1.23 to 2.15). Current vapers had significantly lower risk in wheezing and related respiratory symptoms compared with current smokers (aOR=0.68, 95% CI: 0.53 to 0.87). No significant differences were found between dual users and current smokers in risk of wheezing and related respiratory symptoms (aOR=1.06, 95% CI: 0.91 to 1.24). Conclusions Vaping was associated with increased risk of wheezing and related respiratory symptoms. Current vapers had lower risk in wheezing and related respiratory symptoms than current smokers or dual users but higher than non-users. Both dual use and smoking significantly increased the risk of wheezing and related respiratory symptoms.Keywords
Funding Information
- National Institute of Health
- National Cancer Institute and Food and Drug Administration
- National Center for Advancing Translational Sciences of the National Institutes of Health
This publication has 31 references indexed in Scilit:
- Design and methods of the Population Assessment of Tobacco and Health (PATH) StudyTobacco Control, 2016
- Deeming Tobacco Products To Be Subject to the Federal Food, Drug, and Cosmetic Act, as Amended by the Family Smoking Prevention and Tobacco Control Act; Restrictions on the Sale and Distribution of Tobacco Products and Required Warning Statements for Tobacco Products. Final rule.2016
- Association between Electronic Cigarette Use and Asthma among High School Students in South KoreaPLOS ONE, 2016
- The Role of Nicotine in the Effects of Maternal Smoking during Pregnancy on Lung Development and Childhood Respiratory Disease. Implications for Dangers of E-CigarettesAmerican Journal of Respiratory and Critical Care Medicine, 2016
- Cherry-flavoured electronic cigarettes expose users to the inhalation irritant, benzaldehydeThorax, 2016
- Annual Healthcare Spending Attributable to Cigarette SmokingAmerican Journal of Preventive Medicine, 2014
- Health-Related Effects Reported by Electronic Cigarette Users in Online ForumsJournal of Medical Internet Research, 2013
- 21st-Century Hazards of Smoking and Benefits of Cessation in the United StatesNew England Journal of Medicine, 2013
- Overweight, Obesity, and Incident AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Reliability and validity of interview data on chronic diseases The mini-Finland health surveyJournal of Clinical Epidemiology, 1993